Some Florida dentists say their patients on weight-loss medications report these concerns
Eli Lilly and Company issued a public warning that some compounded versions of #tirzepatide the active ingredient in #Mounjaro and #Zepbound may produce unknown impurities when mixed with additional substances such as vitamin B12
The most cited single result is from Yun and colleagues in 2018, who showed that NLY01, a long-acting PEGylated GLP-1R agonist, blocked the microglia-driven conversion of resting astrocytes into the neurotoxic A1 phenotype in mouse models, a process implicated in neuronal death in both Parkinsons and Alzheimers disease [4]
No official Summary of Product Characteristics (SmPC), Patient Information Leaflet, or approved shelf-life exists for retatrutide
Think of this classification as a yellow warning light rather than a red stop signits not proven dangerous, but its not proven safe either
While these effects are often cited by users, there is currently insufficient clinical evidence to show that combining them with Retatrutide improves recovery, sleep or long-term treatment outcomes